University Of Heidelberg Medical Center
Clinical trials sponsored by University Of Heidelberg Medical Center, explained in plain language.
-
Three-Pronged attack on blood cancer: experimental combo therapy trial opens
Disease control Recruiting nowThis study is testing the safety and effectiveness of three different experimental drug combinations for people newly diagnosed with multiple myeloma who are eligible for a stem cell transplant. The trial will enroll 160 participants to compare different treatment sequences, incl…
Phase: PHASE2 • Sponsor: University of Heidelberg Medical Center • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
New drug combo aims to keep blood cancer at bay
Disease control Recruiting nowThis study is for people with multiple myeloma who have already had a stem cell transplant. It compares two maintenance treatments to see which one is better at keeping the cancer from coming back. One group gets a pill called iberdomide, and the other gets that same pill plus an…
Phase: PHASE3 • Sponsor: University of Heidelberg Medical Center • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC